GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CFT-8634
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: CFT8634 is an orally bioavailable BRD9 degrader that was developed by C4 Therapeutics for potential to treat BRD9-dependent tumours. BRD9 degradation is predicted to offer a more effective option than BRD9 inhibition. Its chemical structure was disclosed at the AACR spring meeting in 2022.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Ligand families/groups | PROTACs, molecular glues and other degraders | 
| Synonyms  | 
| CFT-8634 | 
| Database Links  | |
| CAS Registry No. | 2704617-96-7 (source: PubChem) | 
| GtoPdb PubChem SID | 464244106 | 
| PubChem CID | 163322333 | 
| Search Google for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N | 
| Search Google for chemicals with the same backbone | GNRGNRCQXHMQQV | 
| UniChem Compound Search for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖